Literature DB >> 8703036

Receptor-associated protein is a folding chaperone for low density lipoprotein receptor-related protein.

G Bu1, S Rennke.   

Abstract

The 39-kDa receptor-associated protein (RAP) is a receptor antagonist that inhibits ligand interactions with the receptors that belong to the low density lipoprotein receptor gene family. Our previous studies have demonstrated that RAP interacts with the low density lipoprotein receptor-related protein (LRP) within the endoplasmic reticulum and prevents premature interaction of ligands with the receptor. To analyze whether RAP is also involved in the folding of LRP during receptor biosynthesis, we generated anchor-free, soluble minireceptors that represent each of the four putative ligand-binding domains of LRP (SLRP1, -2, -3, and -4, corresponding to the clusters with 2, 8, 10, and 11 cysteine-rich complement-type repeats, respectively). When these SLRPs were overexpressed by cell transfection, only SLRP1 was secreted. Little or no secretion was observed for SLRP2, -3, and -4. However, when RAP cDNA was cotransfected with SLRP2, -3, and -4 cDNAs, each of these SLRPs was secreted. The cellular retention of SLRPs in the absence of RAP coexpression appeared to be a result of the formation of SDS-resistant, oligomeric aggregates observed under nonreducing conditions. Such oligomers of the SLRPs likely resulted from formation of intermolecular disulfide bonds since they were reduced to monomers when analyzed under reducing conditions. The oligomers were formed not only among molecules of a given SLRP, but also between different SLRPs. The role of RAP in the process of LRP folding was shown by the reduction in aggregated SLRP oligomers upon RAP coexpression. A similar role of RAP in preventing the aggregation of newly synthesized receptor was also observed using membrane-containing minireceptor of LRP. Coimmunoprecipitation and ligand binding studies demonstrated that RAP binds avidly to SLRP2, -3, and -4, but not to SLRP1. These results suggest that these interactions may be important for proper folding of LRP by ensuring the formation of proper intradomain, but not intermolecular or interdomain, disulfide bonds. Thus, our results strongly suggest that, in addition to the prevention of premature binding of ligands to LRP, RAP also plays an important role in receptor folding.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8703036     DOI: 10.1074/jbc.271.36.22218

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Identification of a major cyclic AMP-dependent protein kinase A phosphorylation site within the cytoplasmic tail of the low-density lipoprotein receptor-related protein: implication for receptor-mediated endocytosis.

Authors:  Y Li; P van Kerkhof ; M P Marzolo; G J Strous; G Bu
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

2.  Promotion of transferrin folding by cyclic interactions with calnexin and calreticulin.

Authors:  I Wada; M Kai; S Imai; F Sakane; H Kanoh
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

3.  Sequencing of the entire coding region of the receptor associated protein (RAP) in patients with primary hypothyroidism of unknown origin.

Authors:  S Lisi; R Botta; A Pinchera; C Di Cosmo; A Perri; G De Marco; F Menconi; M Marinò
Journal:  J Endocrinol Invest       Date:  2007-11       Impact factor: 4.256

Review 4.  Receptor-mediated endocytosis in renal proximal tubule.

Authors:  Erik Ilsø Christensen; Pierre J Verroust; Rikke Nielsen
Journal:  Pflugers Arch       Date:  2009-06-05       Impact factor: 3.657

5.  A fragment of secreted Hsp90α carries properties that enable it to accelerate effectively both acute and diabetic wound healing in mice.

Authors:  Chieh-Fang Cheng; Divya Sahu; Fred Tsen; Zhengwei Zhao; Jianhua Fan; Rosie Kim; Xinyi Wang; Kathryn O'Brien; Yong Li; Yuting Kuang; Mei Chen; David T Woodley; Wei Li
Journal:  J Clin Invest       Date:  2011-10-24       Impact factor: 14.808

6.  MicroRNA-205 inhibits tumor cell migration through down-regulating the expression of the LDL receptor-related protein 1.

Authors:  Heesang Song; Guojun Bu
Journal:  Biochem Biophys Res Commun       Date:  2009-08-08       Impact factor: 3.575

7.  Receptor-associated protein interacts with amyloid-beta peptide and promotes its cellular uptake.

Authors:  Takahisa Kanekiyo; Guojun Bu
Journal:  J Biol Chem       Date:  2009-10-13       Impact factor: 5.157

8.  Low-density lipoprotein receptor-related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metalloproteinases 2 and 9.

Authors:  Heesang Song; Yonghe Li; Jiyeon Lee; Alan L Schwartz; Guojun Bu
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

9.  K Domain CR9 of Low Density Lipoprotein (LDL) Receptor-related Protein 1 (LRP1) Is Critical for Aggregated LDL-induced Foam Cell Formation from Human Vascular Smooth Muscle Cells.

Authors:  Paula Costales; Pablo Fuentes-Prior; Jose Castellano; Elena Revuelta-Lopez; Maria Ángeles Corral-Rodríguez; Laura Nasarre; Lina Badimon; Vicenta Llorente-Cortes
Journal:  J Biol Chem       Date:  2015-04-27       Impact factor: 5.157

10.  APP independent and dependent effects on neurite outgrowth are modulated by the receptor associated protein (RAP).

Authors:  Andrew J Billnitzer; Irina Barskaya; Cailing Yin; Ruth G Perez
Journal:  J Neurochem       Date:  2012-11-15       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.